From fragile skin to living medicine: Lessons from RDEB
Podcast: BioSpacePublished On: Thu Jun 18 2026
Description: In this episode of Denatured, you'll hear from Mark Lowdell, CSO & co-founder at INmuneBio Inc. and Vishwas Seshadri, CEO & director at Abeona Therapeutics. We examine how recessive dystrophic epidermolysis bullosa serves as a model for cell and gene therapy, and what this ultra-rare disease teaches us about scaling advanced treatments for the future. Host Jennifer C. Smith-Parker, Director of Insights, BioSpace Guests Mark Lowdell, CSO & Co-Founder, INmuneBio Inc Vishwas Seshadri, CEO & Director, Abeona Therapeutics Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
The note was deleted
The note was saved
Your message was sent